Market Overview

UPDATE: BMO Capital Markets Reiterates Outperform Rating, Raises PT on Cigna Corporation

Share:
Related CI
Leerink Sees Humana Takeout At $220/Share Or More
Anthem-Cigna Deal Will Still Happen, Leerink Says
Humana (HUM) to be Acquired by Aetna for $37B by 2H16 - Analyst Blog (Zacks)

In a report published Monday, BMO Capital Markets reiterated its Outperform rating on Cigna Corporation (NYSE: CI), and raised its price target from $60.00 to $65.00.

BMO Capital noted, “During the Investor Day this year, Cigna outlined its strategy for growth thus far and in the future. International and commercial Healthcare are current and future bright spots, promising ASO membership and above peer expansion. New this year was investor breakout sessions, which allowed attendees to participate in smaller discussion groups with management. Through these sessions, commercial healthcare continues to play an outsized role when it comes to the valuation of CI shares. As presentations marched on, investor concerns continued to analyze the shifting landscape for 2014. Questions around the industry tax, star ratings and exchange dynamics showed that while we are closer to 2014 we still have a lot to learn. We are raising our price target to $65 to reflect the strengthening fundamentals.”

Cigna Corporation closed on Friday at $50.47.

Latest Ratings for CI

DateFirmActionFromTo
Jun 2015RBC CapitalInitiates Coverage onSector Perform
Jun 2015Leerink SwannReiteratesOutperform
Jun 2015Leerink SwannReiteratesOutperform

View More Analyst Ratings for CI
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Price Target Analyst Ratings

 

Related Articles (CI)

Around the Web, We're Loving...

Get Benzinga's Newsletters